Home|Journals|Articles by Year|Audio Abstracts

Research Article

Vaccination of Patients at Risk Against COVID-19: Pros and Cons

*Ksenia V. Tol, Patimat S. Magomedova, Karina M. Idalova,Eliza H. Umatgirieva, Ivan V. Kaska,David S. U. Asanov.


To date, the wave-like development of coronavirus infection continues, and each new round of morbidity takes human lives
with it. In this regard, WHO calls on all citizens of the world to be vaccinated in order to avoid the negative consequences
of a new coronavirus infection.
Vaccination against COVID-19 is not mandatory, but the priorities that vaccinated people receive largely separate them
from those who oppose vaccination. Among the reasons why people refuse vaccination is the presence of chronic diseases
that, in their opinion, may worsen after the introduction of the vaccine or even lead to death. In addition, patients aged
60+ believe that against the background of vaccination, they may develop other diseases that will result from a decrease
in immunity due to age.
Accordingly, the debate about whether there is a need to vaccinate people from the risk group is quite hot, so this
problem appears as relevant in modern conditions. The purpose of the work is to consider the priorities that vaccination
gives to patients at risk, as well as to investigate the risks that may reduce the benefits of vaccination for such citizens.

Key words: COVID-19, Benefit, Harm,Patients, Risk group, Vaccination.

Full-text options

Share this Article

Online Article Submission
• ejmanager.com

ejPort - eJManager.com
Review(er)s Central
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.